Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Needle-free skin patch vaccination method for anthrax.

Gary R Matyas1, Arthur M Friedlander, Gregory M Glenn

  • 1Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA. gary.matyas@na.amed.army.mil

Infection and Immunity
|January 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial.

Human vaccines & immunotherapeutics·2026
Same author

A Comparative Evaluation of Current and Emerging Strategies for Almond Protein Extraction.

Molecules (Basel, Switzerland)·2026
Same author

Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West Africa.

HLA·2026
Same author

Antihypertensive Peptides and Hydrolysates Derived from Plant Proteins and Their Bioavailability.

Foods (Basel, Switzerland)·2026
Same author

Pediatric abusive spine trauma: a review of whole-spine imaging essentials.

Pediatric radiology·2026
Same author

Pediatric low-grade epilepsy-associated tumors (LEATS): neuroimaging review and genetics update.

Pediatric radiology·2026
Same journal

<i>Porphyromonas gingivalis</i> sphingolipids affect early responses of THP-1 macrophages to outer membrane vesicles.

Infection and immunity·2026
Same journal

A genome-wide CRISPR screen defines host determinants of early <i>Brucella</i> infection in human macrophage-like cells.

Infection and immunity·2026
Same journal

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026
Same journal

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same journal

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same journal

<i>Staphylococcus aureus</i> pore-forming toxins differentially shape disease severity in experimental endophthalmitis.

Infection and immunity·2026
See all related articles

Transcutaneous immunization (TCI) with recombinant protective antigen (rPA) in mice generated superior, long-lasting neutralizing antibodies and provided 100% protection against anthrax challenge. This method proved more effective than traditional aluminum-adsorbed rPA.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Anthrax remains a significant biosecurity threat.
  • Effective vaccine strategies are crucial for prophylaxis.
  • Recombinant protective antigen (rPA) is a key component of anthrax vaccines.

Purpose of the Study:

  • To evaluate the efficacy of transcutaneous immunization (TCI) using rPA.
  • To compare TCI with traditional aluminum-adsorbed rPA.
  • To assess the durability of immune response and protection.

Main Methods:

  • Mice were immunized three times with rPA via TCI.
  • Antibody titers were measured over time.
  • A lethal anthrax challenge was administered 46 weeks post-immunization.
  • A control group received aluminum-adsorbed rPA.

Related Experiment Videos

Main Results:

  • TCI with rPA induced superior and long-term neutralizing antibody titers compared to aluminum-adsorbed rPA.
  • rPA alone demonstrated adjuvant activity in the TCI formulation.
  • 100% protection against lethal anthrax challenge was achieved 46 weeks after TCI completion.

Conclusions:

  • Transcutaneous immunization with rPA is a highly effective method for inducing durable immunity against anthrax.
  • TCI offers a promising alternative to conventional parenteral vaccination routes.
  • This approach warrants further investigation for human anthrax prophylaxis.